Kaposi's Sarcoma Associated Herpesvirus Tegument Protein ORF75 Is Essential for Viral Lytic Replication and Plays a Critical Role in the Antagonization of ND10-Instituted Intrinsic Immunity

Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line

(2012) Michael Stürzl et al.   INTERNATIONAL JOURNAL OF CANCER

Construction and Manipulation of a New Kaposi's Sarcoma-Associated Herpesvirus Bacterial Artificial Chromosome Clone

(2012) Kevin F. Brulois et al.   JOURNAL OF VIROLOGY

Herpesvirus Saimiri Antagonizes Nuclear Domain 10-Instituted Intrinsic Immunity via an ORF3-Mediated Selective Degradation of Cellular Protein Sp100

(2012) F. Full et al.   JOURNAL OF VIROLOGY

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100

(2011) M. Adler et al.   JOURNAL OF GENERAL VIROLOGY

Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: Maintenance of tight latency with efficient reactivation upon induction

(2011) Jinjong Myoung et al.   JOURNAL OF VIROLOGICAL METHODS

Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 3 Inhibits Gamma Interferon and Major Histocompatibility Complex Class II Expression

(2011) K. Schmidt et al.   JOURNAL OF VIROLOGY

Evidence for a Dual Antiviral Role of the Major Nuclear Domain 10 Component Sp100 during the Immediate-Early and Late Phases of the Human Cytomegalovirus Replication Cycle

(2011) N. Tavalai et al.   JOURNAL OF VIROLOGY

EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription

(2011) Kevin Tsai et al.   PLoS Pathogens

A Viral Ubiquitin Ligase Has Substrate Preferential SUMO Targeted Ubiquitin Ligase Activity that Counteracts Intrinsic Antiviral Defence

(2011) Chris Boutell et al.   PLoS Pathogens

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?

(2011) Sarah R. Jacobs et al.   Frontiers in Immunology

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine

(2010) Don Ganem   JOURNAL OF CLINICAL INVESTIGATION

Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2

(2010) L. Marcos-Villar et al.   JOURNAL OF GENERAL VIROLOGY

Epigenetic Analysis of KSHV Latent and Lytic Genomes

(2010) Zsolt Toth et al.   PLoS Pathogens

The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes

(2010) Thomas Günther et al.   PLoS Pathogens

Kaposi's Sarcoma-associated Herpesvirus (KSHV) Encodes a SUMO E3 ligase That Is SIM-dependent and SUMO-2/3-specific

(2009) Pei-Ching Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Kaposi's Sarcoma-Associated Herpesvirus Protein LANA2 Disrupts PML Oncogenic Domains and Inhibits PML-Mediated Transcriptional Repression of the Survivin Gene

(2009) L. Marcos-Villar et al.   JOURNAL OF VIROLOGY

A Systems Biology Approach To Identify the Combination Effects of Human Herpesvirus 8 Genes on NF- B Activation

(2009) A. Konrad et al.   JOURNAL OF VIROLOGY

New insights into the role of the subnuclear structure ND10 for viral infection

(2008) Nina Tavalai et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Murine Gammaherpesvirus 68 Open Reading Frame 75c Tegument Protein Induces the Degradation of PML and Is Essential for Production of Infectious Virus

(2008) P. D. Ling et al.   JOURNAL OF VIROLOGY

Virion-Wide Protein Interactions of Kaposi's Sarcoma-Associated Herpesvirus

(2008) R. Rozen et al.   JOURNAL OF VIROLOGY

Multiple Functions for ORF75c in Murid Herpesvirus-4 Infection

(2008) Miguel Gaspar et al.   PLoS One